Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Exchange Rate Effect of -$138000.0 for Q1 2026, down 216.95% year-over-year from $118000.0 in Q1 2025, and down 1433.33% quarter-over-quarter from -$9000.0 in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$138000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 216.95% year-over-year to -$138000.0; the TTM figure through Mar 2026 stood at -$46000.0 (down 284.0% YoY), while the FY2025 annual figure was $210000.0, up 210.53% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$138000.0, down from -$9000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $142000.0 in Q2 2025, with the low at -$238000.0 in Q4 2023.
- The 5-year median for Exchange Rate Effect is -$29000.0 (2022), against an average of -$36470.6.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect plunged 1352.63% in 2023, then soared 847.37% in 2025.
- Amphastar Pharmaceuticals' Exchange Rate Effect stood at $19000.0 in 2022, then slumped by 1352.63% to -$238000.0 in 2023, then surged by 95.38% to -$11000.0 in 2024, then grew by 18.18% to -$9000.0 in 2025, then plunged by 1433.33% to -$138000.0 in 2026.
- Business Quant data shows AMPH's Exchange Rate Effect at -$138000.0 in Q1 2026, -$9000.0 in Q4 2025, and -$41000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 937.04 Mn | 646.91 Mn | 93.47 Mn | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16,000.00 |
| Jun 30, 2026 | 16,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Mar 31, 2024 | -97,000.00 |